BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6192293)

  • 1. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
    Jonsson G; Hallman H
    Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of substance P on neonatally axotomized noradrenaline neurons in rat brain.
    Jonsson G; Hallman H
    Med Biol; 1983 Jun; 61(3):179-85. PubMed ID: 6195493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
    Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental plasticity of central serotonin neurons after 5,7-dihydroxytryptamine treatment.
    Jonsson G; Pollare T; Hallman H; Sachs C
    Ann N Y Acad Sci; 1978 Jun; 305():328-45. PubMed ID: 280250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,7-Dihydroxytryptamine induced changes in the postnatal development of central 5-hydroxytryptamine neurons.
    Sachs C; Jonsson G
    Med Biol; 1975 Jun; 53(3):156-64. PubMed ID: 1160409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P counteracts neurotoxin damage on norepinephrine neurons in rat brain during ontogeny.
    Jonsson G; Hallman H
    Science; 1982 Jan; 215(4528):75-7. PubMed ID: 6171883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord.
    Fusco M; DonĂ  M; Tessari F; Hallman H; Jonsson G; Gorio A
    J Neurosci Res; 1986; 15(4):467-79. PubMed ID: 3522923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
    Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
    Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of substance P levels in the ventral cervical spinal cord of the rat after intracisternal 5,7-dihydroxytryptamine injection.
    Singer E; Sperk G; Placheta P; Leeman SE
    Brain Res; 1979 Oct; 174(2):362-5. PubMed ID: 487135
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 11. Substance P modifies the 6-hydroxydopamine induced alteration of postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Neuroscience; 1982; 7(11):2909-18. PubMed ID: 6185880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum.
    Kirby LG; Kreiss DS; Singh A; Lucki I
    Synapse; 1995 Jun; 20(2):99-105. PubMed ID: 7570349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of cortical neurons to serotonin after 5,7-DHT denervation or PCPA depletion.
    Ferron A; Reader TA; Descarries L
    J Physiol (Paris); 1981; 77(2-3):381-4. PubMed ID: 6457141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neonatal nicotine administration on the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Acta Physiol Scand Suppl; 1980; 479():25-6. PubMed ID: 6932801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain.
    Towle AC; Breese GR; Mueller RA; Hunt R; Lauder JM
    Brain Res; 1986 Jan; 363(1):38-46. PubMed ID: 2418913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Luthman J; Zanoni R
    J Neurosci Res; 1984; 12(2-3):459-75. PubMed ID: 6438349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
    Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
    Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of 6-hydroxydopamine induced alteration of the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Brain Res Bull; 1982; 9(1-6):635-40. PubMed ID: 6184133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.